RxDoctor Payments Data

Dawn Barker, DO

Family Medicine · Springfield, MONPI 1982080255

Payments from drug & device makers

$210in general payments, 2019–2025

Across 12 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$50
  • AstraZeneca$49
  • Abbott$24
  • Pfizer$20
  • Novo Nordisk$18
  • Medtronic$18
  • plus $32 from 2 others

What the payments were for

  • Food & beverage$210100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$210 in reported general payments places this provider in the 40th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$23,890
Medicare patients
132
Services billed
327

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban151$123,734
JardianceEmpagliflozin53$68,295
XareltoRivaroxaban58$51,302
RexultiBrexpiprazole14$40,343
JanuviaSitagliptin Phosphate39$37,353
TrulicityDulaglutide13$30,407
OzempicSemaglutide29$28,712
MounjaroTirzepatide19$20,132
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$20,037
EntrestoSacubitril/Valsartan19$17,925
Breo ElliptaFluticasone/Vilanterol38$17,566
Spiriva HandihalerTiotropium Bromide26$16,061
Victoza 3-PakLiraglutide15$15,670
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog16$14,627
MovantikNaloxegol Oxalate27$12,656

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$20$123,734151 claims
GSKTrelegy Ellipta, Breo Ellipta$17$37,60359 claims
Novo NordiskOzempic$18$28,71229 claims
AstraZenecaFarxiga, Symbicort, Brilinta$49$27,35755 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Springfield

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →